RecruitingPhase 4NCT06379425

Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries

Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries: A Randomized Controlled Trial


Sponsor

Northwell Health

Enrollment

70 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a double-arm randomized control trial evaluating the impact of preoperative opioid-free analgesia on time to trial of void in ambulatory urogynecologic surgeries. The investigators hypothesize that receipt of acetaminophen, celecoxib and gabapentin preoperatively versus acetaminophen alone will reduce the time to trial of void in patients undergoing same-day minor urogynecologic procedures.


Eligibility

Sex: FEMALE

Inclusion Criteria6

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • All female patients over 18 years of age from the Northwell Health urogynecology offices in Bay Shore, Syosset, and Huntington, NY who are undergoing transvaginal minor urogynecologic surgery (midurethral sling, periurethral bulking injections, anterior repair, posterior repair, and perineorrhaphy) at South Shore Surgery Center
  • In good general health as evidenced by medical history
  • Ability to take oral medication and be willing to adhere to the study intervention
  • Patients may be English or Spanish-speaking and must be able to provide informed consent

Exclusion Criteria12

  • Pregnancy or lactation
  • Younger than age 18
  • Known allergic reactions to acetaminophen, celecoxib or gabapentin or any components within the medication formulation
  • Patients with Myasthenia Gravis, renal disease with CrCl < 50, seizure disorder, substance use disorder, anaphylaxis and angioedema to gabapentin, Drug reaction with Eosinophilia and Systemic Symptoms (DRESS), driving impairment, increased seizures suicidal behavior and respiratory depression.
  • Patients with a , history of asthma, urticaria, or other allergic type reactions after taking aspirin or other NSAIDS or DRESS, history of gastric bypass surgery, heart failure, active GI ulcer, active GI bleeding, inflammatory bowel disease, cerebrovascular bleeding, liver impairment/hepatic disease, hyperkalemia.
  • Patients with compromised renal function who are notable to receive NSAIDs
  • Patients with significant cardiovascular disease, such as patients with heart failure
  • Patient with recent evidence of worsening fluid retention
  • Both non-English and non-Spanish speaking patients
  • Urogynecologic surgeries for apical repair (sacrocolpopexy, uterosacral ligament suspension, sacrospinous ligament suspension, colpocleisis)
  • Current use of illicit substances (cocaine, non-prescription opioids, marijuana)
  • Current use of gabapentin as home medication

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAcetaminophen

Will add additional medications celecoxib and gabapentin to acetaminophen preoperatively prior to patient surgery

DRUGCelecoxib

Will add additional medications celecoxib and gabapentin to acetaminophen preoperatively prior to patient surgery

DRUGGabapentin

Will add additional medications celecoxib and gabapentin to acetaminophen preoperatively prior to patient surgery


Locations(1)

Northwell Health South Shore Surgery Center

Bay Shore, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06379425


Related Trials